Buffalo Neuroimaging Analysis Center
Buffalo, New York, United States
Research institute in Buffalo, New York
Buffalo General Hospital D Building, 100 High Street, Buffalo, NY 14203
About Buffalo Neuroimaging Analysis Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University at Buffalo
9
Clinical Trials at Buffalo Neuroimaging Analysis Center
During the past decade, Buffalo Neuroimaging Analysis Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study
2009-03-01
2014-12-01
Completed
159
A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
2012-06-01
2013-02-01
Completed
60
A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
2012-05-01
2013-02-01
Completed
60
Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
2013-06-01
2015-10-01
Completed
50
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
2014-02-01
2014-12-01
Completed
100
Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
2013-11-01
2018-10-01
Completed
50
Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis
2014-07-01
2016-10-01
Completed
150
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Buffalo Neuroimaging Analysis Center"
#1 collaborator was "Teva Pharmaceuticals USA" with 2 trials as a collaborator, "Charles University, Czech Republic" with 1 trials as a collaborator, "General University Hospital, Prague" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Buffalo Neuroimaging Analysis Center
According to Clinical.Site data, the most researched conditions in "Buffalo Neuroimaging Analysis Center" are
"Multiple Sclerosis" (7 trials), "Healthy" (1 trials), "Multiple Sclerosis, Relapsing-remitting" (1 trials), "Tecfidera" (1 trials) and "Teriflunomide" (1 trials). Many other conditions were trialed in "Buffalo Neuroimaging Analysis Center" in a lesser frequency.
Clinical Trials Intervention Types at Buffalo Neuroimaging Analysis Center
Most popular intervention types in "Buffalo Neuroimaging Analysis Center" are "Other" (3 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "MRI" (3 trials), "Dimethyl Fumarate" (1 trials), "Natalizumab discontinuation" (1 trials) and "Teriflunomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Buffalo Neuroimaging Analysis Center
The vast majority of trials in "Buffalo Neuroimaging Analysis Center" are
9 trials for "All" genders.
Clinical Trials Status at Buffalo Neuroimaging Analysis Center
Currently, there are NaN active trials in "Buffalo Neuroimaging Analysis Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Buffalo Neuroimaging Analysis Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Buffalo Neuroimaging Analysis Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".